Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 16 June 2025
Revised: 9 July 2025
Accepted: 10 July 2025
First Online: 29 July 2025
Declarations
:
: MS: nothing to disclose. KT: nothing to disclose. IA: received consultation and/or speaker fees from Biogen, Merck, Novartis, Roche, and Astra Zeneca. MH: received consultation and/or speaker fees from Biogen, Merck, Novartis, Roche, Astra Zeneca, and Amgen
